Kering, GSK and Holcim are adopting science-based targets aimed at protecting land and water globally.

GSK said it acquired an experimental therapy from Chimagen Biosciences that it aims to test in different forms of lupus, and ...

The deal with China’s Chimagen Biosciences is the latest example of pharma interest in exploring the potential of “T cell engagers” in autoimmune disease.

BELGIUMFirst: These steel vats in a new GSK building near Brussels began producing key ingredients for making polio vaccine in 2017—six years after construction began. To maintain sterility ...

Luxury fashion and lifestyle group Kering, pharma giant GSK and building materials producer Holcim have become the first ...

Building trust by delivering sustainable health impact remains a clear priority for all of us at GSK. We continue to make ... reflecting strong performance of new products and the investment ...

India's GlaxoSmithKline Pharmaceuticals reported a higher second-quarter adjusted profit on Tuesday, driven by strong demand for its generic drugs and vaccines.

“Moderna has repeatedly touted the speed at which it produced its original Spikevax vaccine and was later able to modify it to address new viral strains,” GSK said. “But Moderna has ...

AstraZeneca and GSK’s $1 billion investment each to develop new devices has earned them praise ... Speaking in the Eisenhower Executive Office Building in April beside a table where a dozen ...

LONDON — GSK’s once-booming vaccines business met new challenges in the third quarter, as the company lowered sales forecasts for vaccines for the year. Notably, quarterly sales of the ...

Pharmaceutical and agricultural companies are among the industry groups pushing against a proposed levy on their returns from ...

Pacific Trade Invest NZ invites you to an important webinar on the FMCG industry in New Zealand. This will be of great ...